Menu

Jobs for Refugee Scientists

The European Commission has pledged to help find positions for researchers fleeing their home countries.

Oct 7, 2015
Kerry Grens

WIKIPEDIA, MSTYSLAV CHERNOVA new program called science4refugees, launched by the European Commission this week (October 5), intends to find jobs for displaced researchers by hooking them up with “refugee-welcoming organizations.”

“By matching refugees and asylum seekers who have a scientific background with European scientific institutions, the EU [European Union] will gain a huge diversity of new insight for our research, science and innovation, while taking practical steps in providing meaningful opportunities for a vastly talented, but greatly underprivileged, community,” European Commissioner for Research, Science, and Innovation, Carlos Moedas, said in a press release.

Kurt Deketelaere, secretary-general of the League of European Research Universities, told ScienceInsider that several universities are already on board, including the University of Strasbourg in France and the University of Leuven in Belgium.

Another organization, the U.K.-based Council for At-Risk Academics, is also providing aid to scientists who’ve fled from their homes. Executive Director Stephen Wordsworth told ScienceInsider that “anything that helps is welcome.” But, he added, “it’s unclear how many people can benefit” from the commission’s plan, which does not offer any preferential treatment for refugee candidates competing for jobs.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!